Literature DB >> 12593796

hSpry2 is targeted to the ubiquitin-dependent proteasome pathway by c-Cbl.

Amy B Hall1, Natalia Jura, John DaSilva, Yeon Joo Jang, Delquin Gong, Dafna Bar-Sagi.   

Abstract

Sprouty was originally identified in a genetic screen in Drosophila as an antagonist of fibroblast (FGF) and epidermal growth factor (EGF) signaling. Subsequently, four vertebrate homologs were discovered; among these, the human homolog Sprouty 2 (hSpry2) contains the highest degree of sequence homology to the Drosophila protein. It has been shown that hSpry2 interacts directly with c-Cbl, an E3-ubiquitin ligase, which promotes the downregulation of receptor tyrosine kinases (RTKs). In this study, we have investigated the functional consequences of the association between hSpry2 and c-Cbl. We have found that hSpry2 is ubiquitinated by c-Cbl in an EGF-dependent manner. EGF stimulation induces the tyrosine phosphorylation of hSpry2, which in turn enhances the interaction of hSpry2 with c-Cbl. The c-Cbl-mediated ubiquitination of hSpry2 targets the protein for degradation by the 26S proteasome. An enhanced proteolytic degradation of hSpry2 is also observed in response to FGF stimulation. The FGF-induced degradation of hSpry2 limits the duration of the inhibitory effect of hSpry2 on extracellular signal-regulated kinase (ERK) activation and enables the cells to recover their sensitivity to FGF stimulation. Our results indicate that the interaction of hSpry2 with c-Cbl might serve as a mechanism for the downregulation of hSpry2 during receptor tyrosine kinase signaling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12593796     DOI: 10.1016/s0960-9822(03)00086-1

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  56 in total

1.  Bimodal expression of Sprouty2 during the cell cycle is mediated by phase-specific Ras/MAPK and c-Cbl activities.

Authors:  Christoph-Erik Mayer; Barbara Haigl; Florian Jantscher; Gerald Siegwart; Michael Grusch; Walter Berger; Hedwig Sutterlüty
Journal:  Cell Mol Life Sci       Date:  2010-05-12       Impact factor: 9.261

2.  SH3KBP1-binding protein 1 prevents epidermal growth factor receptor degradation by the interruption of c-Cbl-CIN85 complex.

Authors:  Lifeng Feng; Jin-Tao Wang; Hongchuan Jin; Kaixian Qian; Jian-Guo Geng
Journal:  Cell Biochem Funct       Date:  2011-08-09       Impact factor: 3.685

3.  Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.

Authors:  Kimberly Anderson; Kyle A Nordquist; Xianlong Gao; Kristin C Hicks; Bo Zhai; Steven P Gygi; Tarun B Patel
Journal:  J Biol Chem       Date:  2011-10-17       Impact factor: 5.157

4.  Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2.

Authors:  Cristina de Alvaro; Natalia Martinez; Jose M Rojas; Margarita Lorenzo
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

5.  Sef and Sprouty expression in the developing ocular lens: implications for regulating lens cell proliferation and differentiation.

Authors:  Jessica Boros; Peter Newitt; Qian Wang; John W McAvoy; Frank J Lovicu
Journal:  Semin Cell Dev Biol       Date:  2006-10-26       Impact factor: 7.727

6.  Sprouty2 acts at the Cbl/CIN85 interface to inhibit epidermal growth factor receptor downregulation.

Authors:  Kaisa Haglund; Mirko H H Schmidt; Esther Sook Miin Wong; Graeme R Guy; Ivan Dikic
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

7.  CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.

Authors:  Jin-Min Nam; Yasuhito Onodera; Yuichi Mazaki; Hiroyuki Miyoshi; Shigeru Hashimoto; Hisataka Sabe
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

8.  Sprouty4 regulates endothelial cell migration via modulating integrin β3 stability through c-Src.

Authors:  Yan Gong; Xuehui Yang; Qing He; Lindsey Gower; Igor Prudovsky; Calvin P H Vary; Peter C Brooks; Robert E Friesel
Journal:  Angiogenesis       Date:  2013-08-17       Impact factor: 9.596

9.  Receptor tyrosine kinase ubiquitylation involves the dynamic regulation of Cbl-Spry2 by intersectin 1 and the Shp2 tyrosine phosphatase.

Authors:  Mustafa Nazir Okur; Angela Russo; John P O'Bryan
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Authors:  Matthew J Frank; David W Dawson; Steven J Bensinger; Jason S Hong; Wendy M Knosp; Lizhong Xu; Cynthia E Balatoni; Eric L Allen; Rhine R Shen; Dafna Bar-Sagi; Gail R Martin; Michael A Teitell
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.